Even before the COVID-19 epidemic Latinx immigrants were a vulnerable population.

The arrival and rapid spread of COVID-19 in mid-March disrupted virtually all normal operations at Duke.

More than 700 faculty, staff and students tuned into the Duke University School of Medicine’s first

When infected with SARS-CoV-2, why do some people—such as smokers and older adults— have extreme respiratory and cardiovascular distress while others have no symptoms at all?

The HERO registry, which can be joined at HeroesResearch.org, will enroll thousands of healthcare workers to answer crucial questions about the impact of nov

A curious feature of the new coronavirus is that it rarely causes severe symptoms in children.

Researchers and staff at the Duke Human Vaccine Institute and the Duke Regional Biocontainment Laboratory are working around the clock to develop therapies and a vaccine to combat COVID-19.

The Patient-Centered Outcomes Research Institute has funded up to $50 million to evaluate hydroxychloroquine as a preventive drug for the novel coronavirus.

Although most research laboratories at Duke University are shuttered to prevent future transmission of the Covid-19 coronavirus, one of the few to remain open houses a powerful machine that Duke re

The process uses vaporized hydrogen peroxide to kill germs without degrading the masks